- Office: 244K
- Phone: 401.273.7100 x6265
- Email: firstname.lastname@example.org
- Office Location: 7 Greenhouse Road, Kingston, RI 02881
Dr. Taveira’s clinical practice at the Providence VA Medical Center is focused on the provision of pharmaceutical care in the adult ambulatory care setting. Her activities include the provision of direct pharmaceutical care services to high risk patients with chronic conditions, such as hypertension, diabetes, dyslipidemia, and tobacco use in the pharmacist-led Cardiovascular Risk Reduction Clinic (CRRC) and the pharmacist-led group medical visit program. Her research and publications have focused on the evaluation of pharmacist-coordinated cardiac risk reduction care models and the impact of mental health conditions on diabetes and cardiac risk factor control.
Evaluation of pharmacist-coordinated cardiac risk reduction care models and the impact of mental health conditions on diabetes and cardiac risk factor control.
Taveira TH, Wu WC, Martin OJ, Schleinitz MD, Friedman P, Sharma SC. Pharmacist-led cardiac risk reduction model. Prev Cardiol 2006; 9(4):202-8.
Martin OJ, Wu WC, Taveira TH, Eaton CB, Sharma SC. Multidisciplinary group behavioral and pharmacologic intervention for cardiac risk reduction in diabetes – A Pilot Study. Diabetes Educ 2007; 33(1):1118-27.
Pirraglia PA, Taveira TH, Cohen LB, Wu W. Effectiveness of a multifactorial cardiovascular risk reduction clinic for diabetes patients with depression. Prev Chronic Dis 2008; Oct:5(4):A1-7.
Khatana SM, Taveira TH, Miner MM, Eaton CB, Wu WC. Does cardiovascular risk reduction alleviate erectile dysfunction in men with type 2 diabetes mellitus? Int J Impot Res 2008; Sep-Oct;20(5):501-6.
Taveira TH, Pirraglia PA, Cohen LB, Wu WC. Efficacy of a pharmacist-led cardiovascular risk reduction clinic for diabetic patients with and without mental health conditions. Prev Cardiol 2008;11(4):195-200.
Pirraglia PA, Taveira TH, Cohen LB, Dooley AG, Wu WC. Maintenance of cardiovascular risk goals in veterans with diabetes after discharge from a cardiovascular risk reduction clinic. Prev Cardiol 2009;12(1):3-8.
Khatana SA, Taveira TH, Choudhary G, Eaton CB, Wu WC. Change in hemoglobin A1C and C-reactive protein levels in patients with diabetes mellitus. J Cardiometab Synd 2009;4:1-5.
Taveira TH, Friedmann PD, Cohen LB, Dooley AG, Khatana SA, Pirraglia PA, Wu WC. Pharmacist-led group medical appointment model type 2 diabetes. Diabetes Educ 2010;36(1):109-17.
Jankowich MD, Taveira TH, Wu, WC. Decreased lung function is associated with increased arterial stiffness as measured by peripheral pulse pressure: Data from NHANES III. Am J Hypertens 2010;23(6):614-9.
Khatana SA, Taveira TH, Wu WC. The association between C-reactive protein levels and insulin therapy in obese vs. non-obese veterans with type 2 diabetes mellitus. J Clin Hypertens 2010;12(6):462-8.
Cohen LB, Pirraglia PA, Taveira TH, Wu WC. Maintenance of risk factor control in patients with diabetes after discharge from a cardiovascular risk reduction clinic in patients with and without mental health conditions. Ann Pharmacother 2010; 44(7-8):1164-1170.
Khatana SA, Kane J, Taveira TH, Bauer MS, Wu WC. Monitoring and prevalence rates of metabolic syndrome in veterans with major mental illness. PloS One 2011;6(4): e19298. doi:10.1371/journal.pone.0019298
Jankowich MD, Choudhary G. Taveira TH, Wu WC. Age, race, and gender-specific prevalence of diabetes among smokers. Diabetes Res Clin Pract 2011; Sep;93(3):e101-5. Epub 2011 Jun 16.
Cohen LB, Taveira TH, Khatana SA, Dooley AG, Pirraglia PA, Wu WC. Pharmacist-led shared medical appointments for multiple cardiovascular risk reduction in patients with type 2 diabetes. Diabetes Educ 2011 Nov;37(6):801-12. Epub 2011 Oct 21.
Taveira TH, Dooley AG, Cohen LB, Khatana SA,Wu WC. Pharmacist-led group medical appointments for the management of type 2 diabetes with co-morbid depression in older adults. Ann Pharmacother 2011 Nov;45(11):1346-55. Epub 2011 Oct 25.
Malandrino N, Wu WC, Taveira TH, Whitlatch HB, Smith RJ. Association between red blood cell distribution width and macrovascular and microvascular complications in diabetes. Diabetologia 2012 Jan;55(1):226-35. Epub 2011 Oct 15.
Pirraglia PA, Rowland E, Wu WC, Friedmann PD, O’Toole TP, Cohen LB, Taveira TH. The benefits of a primary care clinic co-located and integrated in the mental health setting for veterans with serious mental illness. Prev Chronic Dis. 2012 Feb;9:E51. Epub 2012 Feb 2.
Charpentier MM, Orr KK. Taveira TH. Improving pharmacist knowledge of oral chemotherapy in the community. Ann Pharmacother 2012;46(9):1205-11. doi: 10.1345/aph.1R056. Epub 2012 Aug 28.
Patel N, Taveira TH, Choudhary C, Wu WC. C-peptide levels predict cardiovascular and diabetes related mortality in nondiabetic adults. J Am Heart Assoc 2012 Dec;1(6):e003152. doi: 10.1161/JAHA.112.003152. Epub 2012 Dec 19.
Bharath S, Davis R, Taveira TH, Wu WC. Association between intensity of perioperative glycemic control and postoperative outcomes in the patient with diabetes: A meta-analysis. Diabetes Res Clin Pract 2013;102(1):8 15. doi: 10.1016/j.diabres.2013.05.003. Epub 2013 Jun 6.
Taveira TH, Wu WC, Tschibelu E, Borsook D, Simonson D, Yamamoto R, Langleben DD, Swift R, Elman I. The effect of naltrexone on body fat mass in olanzapine-treated schizophrenic or schizoaffective patients: a randomized double-blind placebo-controlled study. J Psychopharm 2014;28(4):395-400. Doi 10.1177/0269881113509904
Taveira TH, Wu WC. Effectiveness of different strategies in maintaining target goals of cardiovascular risk factors in patients discharged from a cardiovascular risk reduction clinic: A randomized controlled trial. Diabetes Res Clin Pract 2014; Jun 10. pii: S0168-8227(14)00267-8. doi: 10.1016/j.diabres.2014.05.013.